$12.39+0.07 (+0.57%)
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States.
LifeStance Health Group, Inc. in the Healthcare sector is trading at $12.39 with a market capitalization of $4.9B. Wall Street consensus targets $14.40 (10 analysts), implying a +16.2% move over the next 12 months. The stock is currently near its 52-week high of $13.56, remaining 37.5% above its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $435.35Mβ | $403.48Mβ | $382.19Mβ | $363.81Mβ | $345.31M |
| Gross Profit | $153.04Mβ | $135.93Mβ | $126.30Mβ | $116.58Mβ | $108.43M |
| Operating Income | $30.65Mβ | $22.28Mβ | $18.08Mβ | $7.41Mβ | -$2.95M |
| Net Income | $23.61Mβ | $14.24Mβ | $11.67Mβ | $1.08Mβ | -$3.79M |
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services...